Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest renal failure Stories

2011-11-21 06:52:48

(Ivanhoe Newswire) — Impaired glomerular filtration rate (GFR) in the kidney leads to end-stage renal disease and increases the risk of cardiovascular disease and death. Patients with Type I diabetes are at an increased for kidney disease, but there are no interventions that have proved to prevent impaired GFR in these people. According to this study, intensive diabetes therapy may prevent kidney disease in type I diabetes patients. In the Diabetes Control and Complications Trial...

2011-11-14 11:21:50

NIH-funded study shows long-term benefits Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades. The new finding from a study funded by the National Institutes of Health was published online in the New England Journal of Medicine Nov. 12 to coincide with presentation at a scientific meeting. Compared to conventional therapy, near-normal control of blood glucose beginning soon after diagnosis of type 1 diabetes and...

2011-11-14 11:20:34

Years later participants see benefits of good blood sugar control in reducing slow-progressing complications Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function. This finding comes from more than two decades of research on preventing life-shortening complications of type 1 diabetes. The National Institutes of Health (NIH) funded the longitudinal study. Results will be...

2011-11-14 11:17:36

Maintaining normal blood glucose levels prevents long-term kidney complications Highlights:     People with type 1 diabetes are at high risk of developing kidney disease.     Intensive diabetes therapy can preserve kidney function in patients with type 1 diabetes.     Between one million and three million Americans may have type 1 diabetes. Each year, more than 15,000 children and 15,000 adults - approximately 80 people per day - are...

2011-11-14 11:16:40

Anticipated dialysis clinic closures could compromise care; New initiative hopes to improve Americans' kidney health Highlights:     Medicare will soon reduce reimbursements to some dialysis facilities, which may lead to closures. Patients will have to drive further to get care at other facilities, which could compromise their health.     The Healthy People initiative provides 10-year national objectives for improving the health of all Americans. Healthy...

2011-11-11 01:45:46

Diabetics with kidney failure shouldn't lower their blood glucose as much as diabetics without kidney failure Highlights:     Diabetic patients with kidney failure benefit the most when their hemoglobin A1C levels, which reflect blood glucose levels, are between 7% and 8%.     For diabetics who need dialysis, hemoglobin A1C levels of 8% or greater or less than 7% put them at increased risk of dying prematurely compared to patients with levels between 7.0%...

2011-11-10 15:37:05

Kids of minority races less likely to get a kidney transplant before needing dialysis; Blacks with no health insurance more likely to die while waiting for a transplant Highlights:     Pediatric racial minorities are much less likely than whites to get kidney transplants before they need dialysis, regardless of their families' income.     Among children with kidney failure waiting for a transplant, blacks with no health insurance are more likely to die...

2011-11-10 09:17:00

LAWRENCE, Mass. and PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, today announced that Ashita Tolwani, M.D., and William Fissell, M.D., recipients of a NxStage Research Grant, conducted a multi-center study evaluating the removal of Piperacillin during continuous renal replacement therapy (CRRT) in an acute setting for...

2011-11-08 07:20:00

NEWTOWN SQUARE, Pa., Nov. 8, 2011 /PRNewswire/ -- Kibow Biotech, Inc. (a suburban Philadelphia-based Company) announced today, at the occasion of Renal Week, it is changing the brand name of its flagship product to "RENADYL(TM)." Formerly known as Kibow® Biotics, this patented and clinically tested probiotic formulation helps maintain healthy kidney function. At a time when there is growing recognition of the scientific and health benefits of probiotics, Kibow has opted...

2011-11-07 06:00:00

CAPE CORAL, Fla., Nov. 7, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV) announced that it has executed the formal closing documents and acquired the chronic kidney disease (CKD) formula. This formula was developed to restore proper kidney function. Chronic kidney disease (CKD) is a growing health problem in the United States. A report by the Centers for Disease Control (CDC) determined that 16.8% of all adults above the age of 20...